Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: Argentina Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20081
20131
20151
20171
20181
20201
20212
20221
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Hoffmann-La Roche2
Amgen1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
GlaxoSmithKline1
Grupo Oncologico Cooperativo del Sur1
International Agency for Research on Cancer1
Latin American Cooperative Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms15
Neoplasms2
Recurrence2
Squamous Cell Carcinoma of Head and Neck2
Adenocarcinoma1
Adenocarcinoma of Lung1
Biliary Tract Neoplasms1
Carcinoma1
Carcinoma, Hepatocellular1
Carcinoma, Neuroendocrine1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.